Our Medical Affairs Committee (MAC), comprised of Priority Health network physicians, met in February and approved the following medical policy updates. These changes will go into effect on Mar. 1, 2026.
| Medical policy | Details |
| Benign Prostatic Hyperplasia and Urethral Stricture Treatments (#91642) | Additions:
|
| Chelation Therapy (#91077) | Clarification: Policy was restructured to list not medically necessary conditions in one section |
| Enuresis Therapy (#91418) | Added non-covered services:
|
| Extracorporeal Shock Wave Therapy (ESWT) (#91527) |
|
| Gastroesophageal Reflux Disease (GERD) and Barrett’s Esophagus (#91483) |
|
| Gastroparesis Testing and Treatment (#91572) |
|
| Histotripsy (#91649) | New policy
|
| Infusion Services and Equipment (#91414) |
|
| Orthognathic Surgery (#91273) | Clarifications:
|
| Orthotics / Orthoses / Support Devices (#91339) |
|
| Sleep Apnea: Obstructive & Central (#91333) | Change (broadening criteria): Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea (e.g., Inspire Upper Airway Hypoglossal Nerve Stimulator) will be considered medically necessary when the applicable InterQual® criteria are met (CP:Procedures Hypoglossal Nerve Stimulation). |